期刊文献+

固相萃取-高效液相色谱法测定银杏叶提取物中芦丁、槲皮素、山柰酚和异鼠李素 被引量:15

Determination of rutin,quercetin,kaempferol,and isorhamnetin in extract of Ginkgo biloba leaves by HPLC with solid phase extraction
原文传递
导出
摘要 目的建立固相萃取-反相高效液相色谱法同时测定银杏叶提取物中芦丁、槲皮素、山柰酚和异鼠李素的方法。方法采用Waters Sep-Park-C18固相萃取小柱对银杏叶提取物样品进行处理,流动相:甲醇-0.1%甲酸水溶液,线性梯度洗脱;检测波长:360nm;柱温:40℃;进样量:20μL;体积流量:1.0mL/min。结果芦丁、槲皮素、山柰酚、异鼠李素的定量限分别为20、6、5、5mg/mL,芦丁、槲皮素、山柰酚、异鼠李素分别在14~198、15~205、3~40、3~41mg/L时与峰面积线性关系良好,回收率为93.7%~104.7%,日内及日间精密度的RSD分别小于2%、3%。结论方法简单、准确,为银杏叶提取物中黄酮类成分的质量控制提供了依据。 Objective To determine four flavonol components as markers, rutin, quercetin, kaempferol, and isorhamnetin for quality control of extract of Ginkgo biloba (EGb) by a validated high performance liquid chromatographic (HPLC) method with solid phase extraction. Methods The four flavonols of EGb were extracted with Waters Sep-Park-C18 solid-phase extraction column. Separation was achieved using a Kromasil C18 column (250 mm×4.6 mm, 5 μm ) at 40 ℃ with a step linear gradient using methanol : 0.1% formic acid at a flow rate of 1.0 mL/min, wavelength was 360 nm, sample amount was 20μL. Results The limits of quantitation for rutin, quercetin, kaempferol, and isorhamnetin were 20, 6, 5, and 5 mg/mL, respectively. This method was linear over concentration ranges of 14--198, 15--205, 3--40 and 3--41 mg/L for rutin, quercetin, kaempferol, and isorhamnetin, respectively. The solid phase extraction recoveries for rutin, quercetin, kaempferol, and isorhamnetin were 93.7%-104.7%. The precision of intra-day and inter-day were less than 2 % and 3% for all compounds, repectively. Conclusion The validated method is simple, accurate, and able to provide the basis for the quality control of flavonols in EGb.
出处 《中草药》 CAS CSCD 北大核心 2009年第1期56-60,共5页 Chinese Traditional and Herbal Drugs
基金 江苏省高校自然科学基金资助项目(07KJD360225)
关键词 银杏叶提取物(EGb) 固相萃取 HPLC extract of Ginkgo biloba leaves (EGb) solid-phase extraction HPLC
  • 相关文献

参考文献11

二级参考文献26

  • 1谢培山.关于银杏叶制剂的质量控制及质量标准的意见和商榷[J].中药新药与临床药理,1996,7(2):1-3. 被引量:11
  • 2游松.银杏的化学及药理研究进展[J].沈阳药学院学报,1998,5(2):142-142.
  • 3VAN BEEK TERRIS.Ginkgo biloba[M].Amsterdm:Hardwood Academc Publishers,2000.109-142.
  • 4梁逸曾 俞汝勤.分析化学手册(第十分册),化学计量学[M].北京:化学工业出版社,2001..
  • 5[1]Funfgeld E W, Rokan Ginkgo biloba. Resent Results in Pharmacology and Clinic. Springer-verlag Berlin, Heidelberg, NewYork,London, Paris, Tokyo,1988.
  • 6[2]McKenna D J, Jones K, Hughes K. Efficacy, Safety and Use of Ginkgo Biloba in Clinical and Preclinical Applications. Altern Ther Health Med, 2001,7(5) :70,88.
  • 7[3]Liu B, Anderson D, Ferry DR, et al. Determination of Quercetin in Human Plasma Using Reversed-phase High-performance Liquid Chromatography. J Chromatogr B Biomed Appl, 1995,666: 1,149.
  • 8[4]Watson D G, Oliveira E J. Solid-phase Extraction and Gas Chromatography-mass Spectrometry Determination of Kaempferol and Quercetin in Human Urine After Consumption of Ginkgo biloba Tablets. J chromatogr B Biomed Sci Appl, 1999,723(1-2) :203.
  • 9[5]Nielsen S E, Dragsted L O. Column-switching High-Performance Liquid Chromatographic Assay for the Determination of Quercetin in Human Urine with Ultraviolet Absorbance Detection. J Chromatogr B Biomed Sci Appl, 1998,707(1-2) :81.
  • 10Aboud HE. Growth factors and diabetic nephropathy: an overview[J].Kindey Int, 1997,52(S60) :S3-6.

共引文献42

同被引文献2067

引证文献15

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部